PCM4EU

The Norwegian Cancer Symposium 2024 is marking the 70th anniversary of Institute for Cancer Research at @Oslounivsykehus. Keynote speaker #DouglasHanahan kicked-off the scientific program with an excellent talk about Hallmarks of Cancer 2024.

Check out the PCM4EU podcast episode on the importance of patient advocacy. Patient advocate Warnyta Minnaard a.o. discusses securing reimbursement for molecular profiling for CUP patients in the Netherlands: youtube.com/watch?v=jWzY-1…

The next Acta Oncologica Nordic Precision Cancer Medicine Symposium will take place in Oslo 15-17 September 2025 - save the date! A special NPCM symposium collection originating from the NPCM2023 conference has now been published. For more information: matrix-fkb.no/en/news/upcomi…

PCM4EU’s white paper on molecular assays and molecular tumor boards for trial inclusion has been published in Journal of Internal Medicine👏 - many congratulations: matrix-fkb.no/en/pcm4eu-news…

The PCM4EU Spring Academy Opening Symposium hosted by @IPOPorto is addressing precision cancer medicine, focussing both on the past, the present & the future. Thanks to all the speakers for excellent presentations and discussions!

PCM4EU in Porto - warming up to the Spring Academy starting tomorrow with a good project meeting hosted by @IPOPorto. Thank you to the organizers for an excellent start of this event👏👏

Check out our short video introducing the PCM4EU and @PRIMEROSE_EU collaborative initiatives: youtube.com/shorts/m_rTyu8… Thank you to the team at Centre Leon Berard in Lyon for putting this together👏

The PCM4EU team present an interview with #MarenKoban, Director at Merck: Pharmaceutical perspective and involvement in access to cross-border care: youtu.be/cW58cix7kEE?si…

We congratulate @KjetilTasken on receiving the Acta Oncologica Award 2024. Yesterday he gave the Acta Oncologica Honorary Lecture at #Onkologidagarna in Malmø: matrix-fkb.no/no/aktuelt/kje…

The PCM4EU Spring Academy takes place in Porto on 3-6 April! Day 1 is open to the general Public on-site or digitally whereas the following three days are for registered on-site participants. Learn more and down-load the program: matrix-fkb.no/en/pcm4eu-news… #eucancerplan

The PCM4EU podcast team has produced several episodes on cross-border access to clinical trials. Check out the interview with Dr Teodora Lalova-Spinks, lawyer and postdoc at KU Leuven, about cross-border access in EU: youtu.be/2zC1IiBf4mA?si… via @YouTube

Check out our editorial on the European intitiatives @PCM4EU and @PRIMEROSE_EU to combine expertise across borders to implement equitable and sustainable precision cancer medicine, published in HealthcareTech Outlook end of 2023: …logy-europe.healthcaretechoutlook.com/cxoinsights/co…

Our training and education team has produced almost 40 podcast episodes and replays from webinars in 1 year👏These are available both from the PCM4EU YouTube channel and our website. The latest addition is a series of episodes on cross-border access: matrix-fkb.no/en/pcm4eu-news…

We are very happy to announce a research collaboration with @nanopore to explore the clinical value of #nanopore sequencing in precision cancer medicine: matrix-fkb.no/en/news/oxford… @HRussnes @KjetilTasken @HellandAslaug @Oslounivsykehus @forskningsradet @Kreftforeningen

PRIME-ROSE and the #DRUP-like clinical trial community presented several posters at #ESMO2023. Great to see so many lively discussions about #precisioncancermedicine!

The first PRIME-ROSE hang-out at ESMO2023 in Madrid was a success - good discussions and a great atmosphere! Thank you @EbbaHallersjo @KjetilTasken @livefagereng @tanjajuslin for organizing this nice event.

Thank you #VisionZeroCancer, the #EmbassyofSweden in Spain and #BusinessSweden for hosting us all tonight at Join Sweden! ESMO 2023 #EbbaHallersjöHult, #AndersEdsjö, #EdvardAbel

The Molecular Analyses for Precision Oncology Congress 2023 in Paris, October 4-5. PCM4EU present both at the poster session with @ManonAntouly and #loicverlingue and with an oral presentation by @BettinaRyll about the patient perspective on pan-cancer trials and access to drugs.

PCM4EU WP6 produces training resources on precision cancer medicine. Check out our podcast series - altogether 23 episodes are currently available from the PCM4EU website: matrix-fkb.no/en/pcm4eu/trai…

The official opening of PRIME-ROSE took place in Oslo this week and gathered around 70 participants. Read more about the kick-off and download the press release here: matrix-fkb.no/prime-rose-new…